Top Markets
Coin of the day
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
株式のランク #7952
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
株価
$3.11
時価総額
$1.41B
変化(1日)
-1.97%
変化(1年)
-57.22%
CN
取引 Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

カテゴリー

Staidson (Beijing) BioPharmaceuticals Co., Ltd.(300204)の株価履歴
終値の最高値: $3.38 (2026-08-01)

終値の最安値: $1.01 (2011-04-01)
Staidson (Beijing) BioPharmaceuticals Co., Ltd. の株価履歴(2011 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 5.61%
2025 251.84%
2024 -26.03%
2023 -29.22%
2022 -22.33%
2021 84.25%
2020 -2.73%
2019 -4.89%
2018 -25.27%
2017 -17.93%
2016 -37.14%
2015 89.87%
2014 4.94%
2013 1.98%
2012 47.53%
2011 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$541.63 38.15%
US
$1.03K 45.67%
NL
$121.53 -12.48%
AU
$137.73 462.87%
US
$759.27 6.90%
CH